Review



inactivated monovalent ev71 vaccine  (Sinovac BioTech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sinovac BioTech inactivated monovalent ev71 vaccine
    Inactivated Monovalent Ev71 Vaccine, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactivated+monovalent+ev71+vaccine/ev71+vaccine/pm35678636-12-46-56
    Average 90 stars, based on 1 article reviews
    inactivated monovalent ev71 vaccine - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Vaccines:

    Article Title: Epidemiological characteristics of hand, foot, and mouth disease in Yunnan Province, China, 2008–2019
    Article Snippet: .. Three inactivated monovalent EV71 vaccines from Beijing Vigoo Biological Co., Ltd. (Vigoo), Sinovac Biotech Co., Ltd. (Sinovac), and the Institute of Medical Biology, Chinese Academy of Medical Sciences (Kunming Institute) were recently licensed in China, which showed high efficacy (90.0–97.4%) against EV71-associated HFMD but no cross-protection against HFMD caused by CV-A16 or other serotypes in children [ – ]. ..

    Article Title: A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial
    Article Snippet: .. Three inactivated monovalent EV71 vaccines (developed by Chinese Academy of Medical Sciences(CAMS), Sinovac Biotech, and Beijing Vigoo Biological) were licensed in China since 2016, which showed high efficacy (94.8–97.4%) against EV71-associated HFMD but no cross-protection against HFMD caused by other serotypes in children. ..

    other:

    Article Title: A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial.
    Article Snippet: Enterovirus 71 (EV71) is one of the major pathogens causing hand, foot, and mouth disease (HFMD), causing a substantial disease burden in the Asia-Pacific region particularly in young children under 5 years old.1 Currently, there is no specific treatment for HFMD caused by EV71.2 Three inactivated monovalent EV71 vaccines (developed by Chinese Academy of Medical Sciences(CAMS), Sinovac Biotech, and Beijing Vigoo Biological) were licensed in China since 2016, which showed high efficacy (94.8–97.4%) against EV71-associated HFMD but no crossprotection against HFMD caused by other serotypes in children.3–5 Therefore, other kinds of enterovirus vaccine, such as monovalent Coxsackievirus 16(CA-16) vaccine and bivalent EV71 and CA-16 vaccine, are under development.6,7 An applicable immunological surrogate of protection would help to avoid new large trials and facilitate getting new products and formulations approved.



    Similar Products

    inactivated monovalent ev71 vaccine  (Sinovac BioTech)
    90
    Sinovac BioTech inactivated monovalent ev71 vaccine
    Inactivated Monovalent Ev71 Vaccine, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inactivated+monovalent+ev71+vaccine/ev71+vaccine/pm35678636-12-46-56
    Average 90 stars, based on 1 article reviews
    inactivated monovalent ev71 vaccine - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results